Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinoma

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Yuen, Jessie Wai Fong ^a   Chung, Grace Tin Yun ^a   Lun, Samantha Wei Man ^a   Cheung, Chartia Ching Mei ^a   To, Ka Fai ^a   Lo, Kwok Wai ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PHOSPHATASE; PHOSPHATIDYLINOSITOL-3,4-BISPHOSPHATE 4-PHOSPHATASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENICITY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DOWN REGULATION; EPIGENETICS; EPITHELIUM CELL; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INOSITOL POLYPHOSPHATE 4 PHOSPHATASE B GENE; MAJOR CLINICAL STUDY; MALE; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIMARY TUMOR; PROMOTER REGION; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CANCER TRANSPLANTATION; CARCINOGENESIS; DNA METHYLATION; ENZYMOLOGY; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; MIDDLE AGED; NASOPHARYNX TUMOR; NUDE MOUSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; VIROLOGY;

ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; EPIGENESIS, GENETIC; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE, NUDE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM TRANSPLANTATION; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORIC MONOESTER HYDROLASES; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84919618244     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105163     Document Type: Article

References (37)

1. Manning BD, Cantley BD (2007) AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274. (Pubitemid 46962095)
2. Engelman JA (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitation. Nat Rev Cancer 9: 550-562.
3. Liu P, Cheng H, Roberts TM, Zhao JJ (2009) Targeting the phosphoinositide 3- kinase pathway in cancer. Nat Rev Drug Discov 8: 627-644.
4. Bertucci MC, Mitchell CA (2013) Phosphoinositide 3-kinase and INPP4B in human breast cancer. Ann N Y Acad Sci 1280: 1-5.
5. Gewinner C, Wang ZC, Richardson A, Teruya-Feldstein J, Etemadmoghadam D, et al. (2009) Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. Cancer Cell 16: 115-125.
6. Ma K, Cheung SM, Marshall AJ, Duronio V (2008) PI(3,4,5)P3 and PI(3,4)P2 levels correlate with PKB/akt phosphorylation at Thr308 and Ser473, respectively; PI(3,4)P2 levels determine PKB activity. Cell Signal 20: 684-94.
7. Navé BT, Ouwens M, Withers DJ, Alessi DR, Shepherd PR (1999) Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J 344 Pt 2: 427-31. (Pubitemid 30011599)
8. Aoki M, Blazek E, Vogt PK (2001) A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. Proc Natl Acad Sci U S A, 98:136-41. (Pubitemid 32095876)
9. Vazquez F, Sellers WR (2000) The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Biochim Biophys Acta 1470: M21-35. (Pubitemid 30070165)
10. Song MS, Salmena L, Pandolfi PP (2012) The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 13: 283-296.
11. Chalhoub N, Baker SJ (2009) PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 4: 127-150.
12. Yuen TL, Cantley LC (2008) PI3K pathway alterations in cancer: variation on a theme. Oncogene, 27: 5497-5510.
13. Lo KW, To KF, Huang DP (2004) Focus on nasopharyngeal Carcinoma. Cancer Cell, 5: 423-428. (Pubitemid 38612865)
14. Lo KW, Chung GT, To KF (2012) Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Semin Cancer Biol 22: 79-86.
15. Tsao SW, Tsang CM, Pang PS, Zhang G, Chen H, et al. (2012) The biology of EBV infection in human epithelial cells. Semin Cancer Biol 22: 137-143.
16. Morrison JA, Gulley ML, Pathmanathan R, Raab-Traub N (2004) Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res 64: 5251-5260. (Pubitemid 39006545)
17. Dawson CW, Tramountanis G, Eliopoulos AG, Young LS (2003) Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J Biol Chem 278: 3694-3704. (Pubitemid 36801094)
18. Fukuda M, Longnecker R (2007) Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway. J Virol 81: 9299-9306. (Pubitemid 47311472)
19. Chung GT, Lou WP, Chow C, To KF, Choy KW, et al. (2013) Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma. J Pathol 231: 311-322.
20. Or YY, Chung GT, To KF, Chow C, Choy KW, et al. (2010) Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma. J Pathol 220: 97-107.
21. Dawson CW, Port RJ, Young LS (2012) The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). Semin Cancer Biol 22: 144-153.
22. Or YY, Hui AB, To KF, Lam CN, Lo KW (2006) PIK3CA mutations in nasopharyngeal carcinoma. Int J Cancer 118: 1065-1067.
23. Chou CC, Chou MJ, Tzen CY (2009) PIK3CA mutation occurs in nasopharyngeal carcinoma but does not significantly influence the disease-specific survival. Med Oncol 26: 322-326.
24. Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, et al. (1999) Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer 83: 121-126. (Pubitemid 29409487)
25. Huang DP, Ho JH, Poon YF, Chew EC, Saw D, et al. (1980) Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int J cancer 26: 127-132. (Pubitemid 10086410)
26. Tsao SW, Wang X, Liu Y, Cheung YC, Feng H, et al. (2002) Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta 1590: 150-158. (Pubitemid 34626778)
27. Chow LSN, Lo KW, Kwong J, Lam EC, To KF, et al. (2004) RASSF1A is a target tumor suppressor at chromosome region 3p21.3 in nasopharyngeal carcinoma. Int J Cancer 109: 839-847. (Pubitemid 38500740)
28. Kwong J. Chow LSN, Wong AYH, Hung WK, Chung GTY, et al. (2007) Epigenetic inactivation of deleted in lung and esophageal cancer 1 (DLEC1) gene in nasopharyngeal carcinoma. Genes Chromosomes Cancer 46: 171-180. (Pubitemid 44913382)
29. Ferron M, Vacher J (2006) Characterization of the murine Inpp4b gene and identification of a novel isoform. Gene 376: 152-161. (Pubitemid 43903577)
30. Lo KW, Kwong J, Hui ABY, Chan SYY, To KF, et al. (2001) High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 61: 3877-3881. (Pubitemid 32720944)
31. Kwong J, Lo KW, To KF, Teo PML, Johnson PJ, et al. (2002) Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 8: 467-473.
32. Shu XS, Li L, Ji M, Cheng Y, Ying J, et al. (2013) FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma. Carcinogenesis 34: 1984-1993.
33. Fedele CG, Ooms LM, Ho M, Vieusseux J, O'Toole SA, et al. (2010) Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers. Proc Natl Acad Sci USA 107: 22231-22236.
34. Hodgson MC, Shao LJ, Frolov A, Li R, Peterson LE, et al. (2011) Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer. Cancer Res 71: 572-582.
35. Perez-Lorenzo R, Gill KZ, Shen CH, Zhao FX, Zheng B, et al. (2014) A tumor suppressor function for the lipid phosphatase INPP4B in melanocytic neoplasms. J Invest Dermatol, 134:1359-1368.
36. Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL, Zhu YH, et al. (2013) MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis 34: 454-463.
37. Song LB, Li J, Liao WT, Feng Y, Yu CP, et al. (2009) The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 119: 3626-3636.